Loss of myelin-associated glycoprotein in kearns-sayre syndrome

Archives of Neurology

Volumn 69, Issue 4, 2012, Pages 490-499

  Lax, Nichola Z ^a   Campbell, Graham R ^a   Reeve, Amy K ^a   Ohno, Nobuhiko ^c   Zambonin, Jessica ^a   Blakely, Emma L ^a   Taylor, Robert W ^a   Bonilla, Eduardo ^d   Tanji, Kurenai ^d   DiMauro, Salvatore ^d   Jaros, Evelyn ^a,b   Lassmann, Hans ^e   Turnbull, Doug M ^a   Mahad, Don J ^a,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b ROYAL VICTORIA INFIRMARY   (United Kingdom)

^c LERNER RESEARCH INSTITUTE   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; CYTOCHROME C OXIDASE; MITOCHONDRIAL DNA; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN BASIC PROTEIN;

ADULT; ARTICLE; AXONAL INJURY; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMYELINATION; DISEASE ASSOCIATION; DNA SEQUENCE; ENCEPHALITIS; FEMALE; GENE; GENE DELETION; GENE MUTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KEARNS SAYRE SYNDROME; LOSS OF FUNCTION MUTATION; MALE; MITOCHONDRIAL RESPIRATION; MTND1 GENE; MTND4 GENE; NERVE CELL LESION; PATHOGENESIS; POLG GENE; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; WHITE MATTER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; AUTOPSY; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; DNA, MITOCHONDRIAL; ELECTRON TRANSPORT COMPLEX IV; FEMALE; GENE DELETION; GENE EXPRESSION REGULATION; HUMANS; KEARNS-SAYRE SYNDROME; MALE; MIDDLE AGED; MITOCHONDRIA; MYELIN BASIC PROTEINS; MYELIN SHEATH; MYELIN-ASSOCIATED GLYCOPROTEIN; NERVE DEGENERATION; NERVE TISSUE PROTEINS; RETROSPECTIVE STUDIES; SUCCINATE DEHYDROGENASE; SYNAPTOPHYSIN; YOUNG ADULT;

EID: 84859999840     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.2167     Document Type: Article

References (31)

1. Aboul-Enein F, Rauschka H, Kornek B, et al. Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases. J Neuropathol Exp Neurol. 2003;62(1):25-33. (Pubitemid 36068890)
2. Gendelman HE, Pezeshkpour GH, Pressman NJ, et al. A quantitation of myelin-associated glycoprotein and myelin basic protein loss in different demyelinating diseases. Ann Neurol. 1985;18(3):324-328. (Pubitemid 15023106)
3. Ludwin SK, Johnson ES. Evidence for a "dying-back" gliopathy in demyelinating disease. Ann Neurol. 1981;9(3):301-305. (Pubitemid 11147150)
4. Quarles RH. Myelin-associated glycoprotein (MAG): past, present and beyond. J Neurochem. 2007;100(6):1431-1448. (Pubitemid 46376206)
5. Rodriguez M. Central nervous system demyelination and remyelination in multiple sclerosis and viral models of disease. J Neuroimmunol . 1992;40(2-3):255-263.
6. RodriguezM, Scheithauer B. Ultrastructure of multiple sclerosis. Ultrastruct Pathol. 1994;18(1-2):3-13. (Pubitemid 24131605)
7. Trapp BD, Quarles RH. Immunocytochemical localization of the myelin-associated glycoprotein: fact or artifact? J Neuroimmunol. 1984;6(4):231-249. (Pubitemid 14065624)
8. Itoyama Y, Webster HD, Sternberger NH, et al. Distribution of papovavirus, myelin-associated glycoprotein, and myelin basic protein in progressive multifocal leukoencephalopathy lesions. Ann Neurol. 1982;11(4):396-407. (Pubitemid 12133701)
9. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000;47(6):707-717. (Pubitemid 30390191)
10. Filosto M, Tomelleri G, Tonin P, et al. Neuropathology of mitochondrial diseases. Biosci Rep. 2007;27(1-3):23-30. (Pubitemid 46940935)
11. DiMauro S, Shon EA. Mitochondrial disorders in the nervous system. Annu Rev Neurosci. 2008;31:91-123.
12. Moraes CT, DiMauro S, Zeviani M, et al. Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome. N Engl J Med. 1989;320(20):1293-1299. (Pubitemid 19140403)
13. Oldfors A, Fyhr IM, Holme E, Larsson NG, Tulinius M. Neuropathology in Kearns- Sayre syndrome. Acta Neuropathol. 1990;80(5):541-546.
14. Tanji K, Vu TH, Schon EA, DiMauro S, Bonilla E. Kearns-Sayre syndrome: unusual pattern of expression of subunits of the respiratory chain in the cerebellar system. Ann Neurol. 1999;45(3):377-383. (Pubitemid 29120043)
15. Jaros E, Mahad DJ, Hudson G, et al. Primary spinal cord neurodegeneration in Leber hereditary optic neuropathy. Neurology. 2007;69(2):214-216. (Pubitemid 47051727)
16. Szigeti K, Sule N, Adesina AM, et al. Increased blood-brain barrier permeability with thymidine phosphorylase deficiency. Ann Neurol. 2004;56(6):881-886. (Pubitemid 39578454)
17. Betts J, Lightowlers RN, Turnbull DM. Neuropathological aspects of mitochondrial DNA disease. Neurochem Res. 2004;29(3):505-511. (Pubitemid 38295001)
18. Old SL, Johnson MA. Methods of microphotometric assay of succinate dehydrogenase and cytochrome c oxidase activities for use on human skeletal muscle. Histochem J. 1989;21(9-10):545-555. (Pubitemid 19259801)
19. Krishnan KJ, Bender A, Taylor RW, Turnbull DM. A multiplex real-time PCR method to detect and quantify mitochondrial DNA deletions in individual cells. Anal Biochem. 2007;370(1):127-129. (Pubitemid 47404486)
20. Reeve AK, Krishnan KJ, Elson JL, et al. Nature of mitochondrial DNA deletions in substantia nigra neurons. Am J Hum Genet. 2008;82(1):228-235. (Pubitemid 351726092)
21. Susin SA, Lorenzo HK, Zamzami N, et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature. 1999;397(6718):441-446.
22. Stefanova N, Bücke P, Duerr S, Wenning GK. Multiple system atrophy: an update. Lancet Neurol. 2009;8(12):1172-1178.
23. Wenning GK, Stefanova N, Jellinger KA, Poewe W, Schlossmacher MG. Multiple system atrophy: a primary oligodendrogliopathy. Ann Neurol. 2008;64(3):239-246.
24. Veto S, Acs P, Bauer J, et al. Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death. Brain. 2010;133(pt 3):822-834.
25. Buss A, Pech K, Merkler D, et al. Sequential loss of myelin proteins during Wallerian degeneration in the human spinal cord. Brain. 2005;128(pt 2):356-364. (Pubitemid 40222604)
26. Buss A, Schwab ME. Sequential loss of myelin proteins during Wallerian degeneration in the rat spinal cord. Glia. 2003;42(4):424-432. (Pubitemid 36702283)
27. Bender A, Krishnan KJ, Morris CM, et al. High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease. Nat Genet. 2006;38(5):515-517.
28. Sciacco M, Bonilla E, Schon EA, DiMauro S, Moraes CT. Distribution of wildtype and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy. Hum Mol Genet. 1994;3(1):13-19. (Pubitemid 24038136)
29. Lutz SE, Zhao Y, Gulinello M, Lee SC, Raine CS, Brosnan CF. Deletion of astrocyte connexins 43 and 30 leads to a dysmyelinating phenotype and hippocampal CA1 vacuolation. J Neurosci. 2009;29(24):7743-7752.
30. Felts PA, Woolston AM, Fernando HB, et al. Inflammation and primary demyelination induced by the intraspinal injection of lipopolysaccharide. Brain. 2005;128(pt 7):1649-1666. (Pubitemid 41373684)
31. Qi X, Lewin AS, Sun L, Hauswirth WW, Guy J. Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis. J Biol Chem. 2006;281(42):31950-31962. (Pubitemid 46041457)